1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Alzheimer's Research Program (AZRP)" is currently closed and not accepting applications.
Alzheimer's Research Program (AZRP) is sponsored by Congressionally Directed Medical Research Programs (CDMRP). The AZRP funds impactful, solution-oriented research to address critical needs and improve the quality of life for Service Members, Veterans, their Families, and the public living with Alzheimer's disease and related dementias.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Alzheimer's Research Program, Congressionally Directed Medical Research Programs You are using an outdated browser. Please upgrade your browser to improve your experience. U.S. Department of War organization.
Due to routine system maintenance the CDMRP website will be unavailable from COB 24 April - 27 April COB. DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS Transforming Health Care through Innovative and Impactful Research Vision – Mitigate the impact of Alzheimer's and related dementias associated with TBI, military, and diverse risks.
Mission – Fund impactful, solution-oriented research to address critical needs and improve quality of life for Service Members, Veterans, their Families, and the public who are living with Alzheimer's disease and related dementias.
» Click on Image to View Program Summary Sheet The AZRP seeks to support transformative research on Alzheimer's Disease/AD-Related Dementias with outcomes relevant to the populations they aim to benefit, including Service Members, Veterans, their Families and the general public.
There is an urgent need to prevent and reduce the risk of developing AD/ADRD, particularly following traumatic brain injury and similar deleterious exposures. Military personnel are at increased risk of developing dementia following their service. The AZRP encourages innovations to accelerate research and interventions in the risk reduction and prevention space.
Those who are at risk of developing AD/ADRD, particularly post-TBI, need early, accurate diagnosis to optimize treatment availability and impact. The AZRP prioritizes research efforts aimed at improving diagnosis and prognosis now including methods, technologies, patient access to diagnosis, and accuracy of diagnosis and prognosis in clinical care. The AZRP supports research that improves the lives of people living with dementia now.
AZRP-supported research should, with a sense of urgency, lead to meaningful outcomes to support caregivers and persons with AD and ADRD. Additionally, the AZRP prioritizes a focus on partnership between researchers and those most impacted by these conditions. The program requires that clinical research projects include community collaboration.
Like millions of Americans and others around the globe, Service Members and Veterans often shoulder the additional responsibility of caring for loved ones with dementia. In situations such as deployment and reassignment, unique pressures and challenges exist for Service Members who serve as care and support partners, which can significantly impact both readiness and personal health.
The AZRP prioritizes research to effectively support quality of life for both the individual living with the diagnosis and their families/care communities. Resources for Investigators: FY25 AZRP Funding Opportunity FAQ Recent Applications Recommended for Funding FY25 Peer Review Participants International Alzheimer's Disease Research Portfolio A Link between TBI and Alzheimer's Disease?
The Advocate's Perspective [Click on image to watch] A Caregiver's Perspective [Click on image to watch] CDMRP-Supported Research Assesses TBI-Related Outcomes to Improve Warfighter Brain Health FY25 AZRP Recommended for Funding List Alzheimer's Research Program Booklet CDMRP-Funded Research Supports Early Detection of Alzheimer's Disease and Related Dementias Unraveling Links Between Cholesterol Markers and Cognitive Decline in Alzheimer's Disease Sound wave technologies: Transforming the future of clinical biofluidic diagnosis Neural Imaging and Machine Learning Approaches to Estimate Brain Age and Post-TBI Decline Human-Specific Circular RNAs as Key Players to Telehealth-Based Mind-Body Interventions to Improve Cognition and Quality of Life in Individuals with MCI and Their Caregivers Katie Brandt: A Caregiver and Advocate s Story Mindy Cameron - Striving to Defeat Duchenne Identifying Pathways that Lead to the Development of Alzheimer's Disease PRARP Previous Highlights… Click here to provide feedback/comments to the AZRP Last updated Monday, June 29, 2026
According to the current listing, eligibility includes: Researchers focusing on Alzheimer's disease and related dementias, with an emphasis on outcomes relevant to Service Members, Veterans, and their Families. Confirm the full requirements in the official notice before applying.
The published deadline was June 29, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Alzheimer's Research Program (AZRP) is funded by Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The Congressionally Directed Medical Research Programs just released $1.27 billion across 34 programs. Universities, nonprofits, and small businesses are all eligible.
Read articleCDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article